Increased infectivity of stationary-phase promastigotes of Leishmania donovani: correlation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 1453286)

Published in Immunology on April 01, 1987

Authors

A O Wozencraft, J M Blackwell

Articles citing this

A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34

Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect Immun (1987) 1.74

Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med (1988) 1.51

Immunological perspectives of leishmaniasis. J Glob Infect Dis (2010) 1.08

Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival. Trends Parasitol (2012) 1.01

Major surface protease of trypanosomatids: one size fits all? Infect Immun (2009) 0.94

Complement interaction with trypanosomatid promastigotes in normal human serum. J Exp Med (2002) 0.90

Stage-specific pathways of Leishmania infantum chagasi entry and phagosome maturation in macrophages. PLoS One (2011) 0.83

Experimental evolution alters the rate and temporal pattern of population growth in Batrachochytrium dendrobatidis, a lethal fungal pathogen of amphibians. Ecol Evol (2014) 0.81

Recent developments in the interactions between caveolin and pathogens. Adv Exp Med Biol (2012) 0.78

Exposure to Leishmania braziliensis triggers neutrophil activation and apoptosis. PLoS Negl Trop Dis (2015) 0.77

Differential surface deposition of complement proteins on logarithmic and stationary phase Leishmania chagasi promastigotes. J Parasitol (2012) 0.75

Articles cited by this

Identification of an infective stage of Leishmania promastigotes. Science (1984) 4.00

Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44

Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice. Clin Exp Immunol (1977) 3.19

Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Am J Pathol (1983) 2.38

Mechanism of lethal effect of human serum upon Leishmania donovani. J Immunol (1980) 2.08

A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology (1984) 1.89

C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol (1986) 1.82

Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J Immunol (1984) 1.66

C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J Immunol (1983) 1.52

A common major surface antigen on amastigotes and promastigotes of Leishmania species. J Exp Med (1985) 1.35

Growth cycle-dependent generation of complement-resistant Leishmania promastigotes. J Immunol (1985) 1.30

Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J Exp Med (1986) 1.28

A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption. J Immunol Methods (1985) 1.14

Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proc Natl Acad Sci U S A (1986) 1.14

Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3. J Immunol (1985) 1.10

Restriction of the alternative pathway of human complement by intact Trypanosoma brucei subsp. gambiense. Infect Immun (1986) 1.02

Articles by these authors

Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med (1995) 2.30

Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature (1982) 2.29

Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis (2001) 2.02

Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol (1991) 2.00

Developmental changes in the glycosylated phosphatidylinositols of Leishmania donovani. Characterization of the promastigote and amastigote glycolipids. J Biol Chem (1991) 1.99

A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology (1984) 1.89

Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect Immun (1991) 1.84

Expression of the natural resistance gene Lsh in resident liver macrophages. Infect Immun (1984) 1.82

Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. J Immunol (1993) 1.78

Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76

Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun (2004) 1.65

Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: linkage study of the candidate genes NRAMP1 and TNFA. Tuber Lung Dis (1997) 1.50

Localisation of Nramp1 in macrophages: modulation with activation and infection. J Cell Sci (1998) 1.50

Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet (1999) 1.43

Modern vaccines. Parasitic diseases. Lancet (1990) 1.41

IL-13 is a susceptibility factor for Leishmania major infection. J Immunol (2000) 1.38

NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. J Exp Med (1994) 1.37

Genome-wide scans for leprosy and tuberculosis susceptibility genes in Brazilians. Genes Immun (2004) 1.36

Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J (2001) 1.36

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun (1999) 1.32

Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol Med (1995) 1.32

The molecular karyotype of the megabase chromosomes of Trypanosoma brucei and the assignment of chromosome markers. Mol Biochem Parasitol (1998) 1.30

Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy. J Exp Med (1986) 1.28

Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Infect Immun (1994) 1.25

Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. J Infect Dis (2000) 1.20

Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice. Infect Immun (1984) 1.20

Identification and characterisation of a functional peroxidoxin from Leishmania major. Mol Biochem Parasitol (1998) 1.20

Nramp1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect Immun (1997) 1.18

Interaction with extracellular matrix proteins influences Lsh/Ity/Bcg (candidate Nramp) gene regulation of macrophage priming/activation for tumour necrosis factor-alpha and nitrite release. Immunology (1994) 1.17

Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: the effects of parasite dose, cyclophosphamide and sublethal irradiation. Parasite Immunol (1983) 1.16

Fetal alcohol exposure and temporal vulnerability: regional differences in cell loss as a function of the timing of binge-like alcohol exposure during brain development. Alcohol Clin Exp Res (1999) 1.14

SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int J Tuberc Lung Dis (2004) 1.14

Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun (2007) 1.14

Nramp1 locus encodes a 65 kDa interferon-gamma-inducible protein in murine macrophages. Biochem J (1997) 1.14

Variable expression of the murine natural resistance gene Lsh in different macrophage populations infected in vitro with Leishmania donovani. Parasite Immunol (1987) 1.14

Polymorphism in the interferon-gamma receptor-1 gene and susceptibility to pulmonary tuberculosis in The Gambia. Scand J Immunol (2003) 1.12

Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun (2006) 1.08

Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics (1983) 1.08

Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice. Infect Immun (1989) 1.07

Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1. Genes Immun (2003) 1.06

Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogenet (1993) 1.06

Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. Genomics (1994) 1.05

Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Infect Immun (1998) 1.05

Acquisition of cell-mediated immunity to Leishmania. II. LSH gene regulation of accessory cell function. Immunology (1988) 1.04

Toxoplasma gondii expressed sequence tags: insight into tachyzoite gene expression. Mol Biochem Parasitol (1996) 1.03

Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis. Genes Immun (2010) 1.03

Intra and inter-specific microsatellite variation in the Leishmania subgenus Viannia. Mol Biochem Parasitol (1999) 1.02

Genetic analysis of Leishmania mexicana infection in mice: single gene (Scl-2) controlled predisposition to cutaneous lesion development. J Immunogenet (1990) 1.02

Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Cancer Epidemiol Biomarkers Prev (2000) 1.02

Genetic epidemiology of visceral leishmaniasis in northeastern Brazil. Genet Epidemiol (2001) 1.01

Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Immunology (1995) 1.01

Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis. Arthritis Rheum (2000) 1.00

Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infect Immun (1988) 1.00

Multiple causes of size variation in the diploid megabase chromosomes of African tyrpanosomes. Chromosome Res (1999) 0.99

Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet (1996) 0.99

Monoclonal antibodies that recognize distinct epitopes of the macrophage type three complement receptor differ in their ability to inhibit binding of Leishmania promastigotes harvested at different phases of their growth cycle. Immunology (1988) 0.99

Altered course of visceral leishmaniasis in mice expressing transgenic I-E molecules. Eur J Immunol (1992) 0.99

An expressed sequence tag analysis of a full-length, spliced-leader cDNA library from Leishmania major promastigotes. Mol Biochem Parasitol (1997) 0.98

A study of the sensitivity of Leishmania donovani promastigotes and amastigotes to hydrogen peroxide. II. Possible mechanisms involved in protective H2O2 scavenging. Parasitology (1985) 0.98

Lsh, antigen presentation and the development of CMI. Res Immunol (1989) 0.98

Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun (2001) 0.97

Expression of LPG and GP63 by different developmental stages of Leishmania major in the sandfly Phlebotomus papatasi. Parasitology (1990) 0.97

The complete chromosomal organization of the reference strain of the Leishmania Genome Project, L. major ;Friedlin'. Parasitol Today (1998) 0.96

Analysis of Lsh gene expression in congenic B10.L-Lshr mice. Curr Top Microbiol Immunol (1988) 0.96

Transfer of innate resistance and susceptibility to Leishmania donovani infection in mouse radiation bone marrow chimaeras. Immunology (1984) 0.95

An Nramp-related sequence maps to mouse chromosome 17. Mamm Genome (1994) 0.94

Unravelling the Leishmania genome. Curr Opin Genet Dev (1996) 0.93

Oxygen radical release by adherent cell populations during the initial stages of a lethal rodent malarial infection. Immunology (1985) 0.92

Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA. Genes Immun (2002) 0.92

Genetic control of recovery from visceral leishmaniasis. Trans R Soc Trop Med Hyg (1982) 0.91

FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil. Genes Immun (2011) 0.91

FBXO11, a regulator of the TGFβ pathway, is associated with severe otitis media in Western Australian children. Genes Immun (2011) 0.91

Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients. Parasite Immunol (2000) 0.90

A study of the sensitivity of Leishmania donovani promastigotes and amastigotes to hydrogen peroxide. I. Differences in sensitivity correlate with parasite-mediated removal of hydrogen peroxide. Parasitology (1985) 0.90

Genome-wide scan for loci influencing quantitative immune response traits in the Belém family study: comparison of methods and summary of results. Ann Hum Genet (2006) 0.90

Typhoid fever and genetic polymorphisms at the natural resistance-associated macrophage protein 1. J Infect Dis (2001) 0.87

Immune response in healthy volunteers vaccinated with BCG plus killed leishmanial promastigotes: antibody responses to mycobacterial and leishmanial antigens. Vaccine (1994) 0.87

An H-11-linked gene has a parallel effect on Leishmania major and L. donovani infections in mice. Immunogenetics (1985) 0.87

Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population. Public Health Genomics (2009) 0.86

No association between interferon-gamma receptor-1 gene polymorphism and pulmonary tuberculosis in a Gambian population sample. Thorax (2004) 0.86

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun (2006) 0.86

Nramp1 is expressed in neurons and is associated with behavioural and immune responses to stress. Neurogenetics (2001) 0.85

Response of BALB/c mice to leishmanial infection. Curr Top Microbiol Immunol (1985) 0.85

Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease. Tissue Antigens (2007) 0.84

Role of macrophage complement and lectin-like receptors in binding Leishmania parasites to host macrophages. Immunol Lett (1985) 0.83

Cell-mediated killing of protozoa. Adv Parasitol (1983) 0.83

Evidence for altered control of hypothalamic CRF in immune-mediated diseases. Ann N Y Acad Sci (1995) 0.83

EcoRV RFLP of the desmin (DES) gene and MspI RFLP of the villin (VIL1) gene on human chromosome 2. Hum Mol Genet (1992) 0.83

Analysing the immune response to L. donovani infection. Ann Inst Pasteur Immunol (1988) 0.83

Cell-mediated pathology during murine malaria-associated nephritis. Clin Exp Immunol (1993) 0.82

Esophageal radionuclide transit tests. Potential false-positive results. Clin Nucl Med (1984) 0.82

Characterization of protective T cells in the acquired response to Leishmania donovani in genetically determined cure (H-2b) and noncure (H-2d) mouse strains. Infect Immun (1989) 0.82

Transmission and scanning EM-immunogold labeling of Leishmania major lipophosphoglycan in the sandfly Phlebotomus papatasi. Eur J Cell Biol (1991) 0.82

Genetics of resistance to infection. Lancet (1982) 0.80

Allele frequency and genotype distribution of polymorphisms within disease-related genes is influenced by ethnic population sub-structuring in Sudan. Genetica (2003) 0.80

Damage to malaria-infected erythrocytes following exposure to oxidant-generating systems. Parasitology (1986) 0.79

Extensive polymorphism at the Gp63 locus in field isolates of Leishmania peruviana. Mol Biochem Parasitol (1995) 0.79

Identification of C to T mutation at position -236 bp in the human NRAMP1 gene promoter. Immunogenetics (1996) 0.79